United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45963-765_0bc8d3b7-f15e-4dbf-b51f-8baaa93b0e61
- Product NDC
- 45963-765
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Docetaxel
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140901
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (45963-765-52) / 4 mL in 1 VIAL, GLASS · 45963-765-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →